Gujarat Alkalies and Chemicals Limited (BOM:530001)
India · Delayed Price · Currency is INR 655.25
+15.85 (2.48%)
At close: Jun 22, 2026
BOM:530001 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 43,581 | 40,729 | 38,066 | 45,165 | 37,587 | |
Revenue Growth (YoY) | 7.00% | 7.00% | -15.72% | 20.16% | 54.71% |
Cost of Revenue | 29,700 | 28,367 | 28,700 | 26,327 | 20,277 |
Gross Profit | 13,881 | 12,362 | 9,366 | 18,838 | 17,310 |
Selling, General & Admin | 3,705 | 3,682 | 3,228 | 2,989 | 3,114 |
Other Operating Expenses | 6,124 | 4,721 | 4,595 | 4,356 | 4,321 |
Operating Expenses | 13,974 | 12,326 | 11,597 | 10,106 | 9,413 |
Operating Income | -92.7 | 36.19 | -2,230 | 8,732 | 7,897 |
Interest Expense | -633.8 | -465.01 | -422.8 | -171.23 | -36.88 |
Interest & Investment Income | - | 517.54 | 752.67 | 380.99 | 361.33 |
Earnings From Equity Investments | -232.5 | -809.37 | -1,046 | -1,661 | -22.17 |
Currency Exchange Gain (Loss) | - | -100.21 | -71.27 | -344.37 | -5.13 |
Other Non Operating Income (Expenses) | 1,166 | 44.78 | -16.39 | -13.55 | -21.93 |
EBT Excluding Unusual Items | 207.2 | -776.08 | -3,034 | 6,923 | 8,172 |
Gain (Loss) on Sale of Investments | - | 51.56 | 30.13 | 29.01 | 96.26 |
Gain (Loss) on Sale of Assets | - | 12.38 | -0.7 | -0.68 | -4.09 |
Pretax Income | 207.2 | -712.14 | -3,005 | 6,951 | 8,264 |
Income Tax Expense | 231.3 | -60.95 | -636.34 | 2,855 | 2,666 |
Net Income | -24.1 | -651.19 | -2,368 | 4,096 | 5,598 |
Net Income to Common | -24.1 | -651.19 | -2,368 | 4,096 | 5,598 |
Net Income Growth | - | - | - | -26.82% | 237.74% |
Shares Outstanding (Basic) | 73 | 73 | 73 | 73 | 73 |
Shares Outstanding (Diluted) | 73 | 73 | 73 | 73 | 73 |
Shares Change (YoY) | -0.55% | - | - | - | - |
EPS (Basic) | -0.33 | -8.87 | -32.25 | 55.78 | 76.22 |
EPS (Diluted) | -0.33 | -8.87 | -32.25 | 55.78 | 76.22 |
EPS Growth | - | - | - | -26.82% | 237.73% |
Free Cash Flow | 1,479 | 557.34 | -1,646 | 2,769 | -1,739 |
Free Cash Flow Per Share | 20.26 | 7.59 | -22.42 | 37.71 | -23.68 |
Dividend Per Share | 17.700 | 15.800 | - | 23.550 | 10.000 |
Dividend Growth | 12.03% | - | - | 135.50% | 25.00% |
Gross Margin | 31.85% | 30.35% | 24.61% | 41.71% | 46.05% |
Operating Margin | -0.21% | 0.09% | -5.86% | 19.33% | 21.01% |
Profit Margin | -0.06% | -1.60% | -6.22% | 9.07% | 14.89% |
Free Cash Flow Margin | 3.40% | 1.37% | -4.32% | 6.13% | -4.63% |
EBITDA | 4,052 | 3,918 | 1,505 | 11,454 | 9,837 |
EBITDA Margin | 9.30% | 9.62% | 3.96% | 25.36% | 26.17% |
D&A For EBITDA | 4,145 | 3,882 | 3,736 | 2,723 | 1,940 |
EBIT | -92.7 | 36.19 | -2,230 | 8,732 | 7,897 |
EBIT Margin | -0.21% | 0.09% | -5.86% | 19.33% | 21.01% |
Effective Tax Rate | 111.63% | - | - | 41.07% | 32.27% |
Revenue as Reported | 44,747 | 41,650 | 38,967 | 45,587 | 38,051 |